Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.
Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Present DH, et al. N Engl J Med. 1980 May 1;302(18):981-7. doi: 10.1056/NEJM198005013021801. N Engl J Med. 1980. PMID: 6102739 Clinical Trial.
6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
Korelitz BI, Present DH. Korelitz BI, et al. Among authors: present dh. J Crohns Colitis. 2014 Aug;8(8):735-8. doi: 10.1016/j.crohns.2013.12.024. Epub 2014 Jan 22. J Crohns Colitis. 2014. PMID: 24462321
6-Mercaptopurine is effective in Crohn's disease without concomitant steroids.
Goldstein ES, Marion JF, Present DH. Goldstein ES, et al. Among authors: present dh. Inflamm Bowel Dis. 2004 Mar;10(2):79-84. doi: 10.1097/00054725-200403000-00003. Inflamm Bowel Dis. 2004. PMID: 15168805
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH. Hanauer SB, et al. Among authors: present dh. Gastroenterology. 2004 Sep;127(3):723-9. doi: 10.1053/j.gastro.2004.06.002. Gastroenterology. 2004. PMID: 15362027 Clinical Trial.
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.
Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Sandborn WJ, et al. Among authors: present dh. Gastroenterology. 2003 Aug;125(2):380-8. doi: 10.1016/s0016-5085(03)00877-1. Gastroenterology. 2003. PMID: 12891539 Clinical Trial.
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease.
Haber CJ, Meltzer SJ, Present DH, Korelitz BI. Haber CJ, et al. Among authors: present dh. Gastroenterology. 1986 Oct;91(4):982-6. doi: 10.1016/0016-5085(86)90703-1. Gastroenterology. 1986. PMID: 2427386
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
Sandborn WJ, Feagan BG, Hanauer SB, Present DH, Sutherland LR, Kamm MA, Wolf DC, Baker JP, Hawkey C, Archambault A, Bernstein CN, Novak C, Heath PK, Targan SR; CDP571 Crohn's Disease Study Group. Sandborn WJ, et al. Among authors: present dh. Gastroenterology. 2001 May;120(6):1330-8. doi: 10.1053/gast.2001.24042. Gastroenterology. 2001. PMID: 11313302 Clinical Trial.
Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Meyers S, Sachar DB, Present DH, Janowitz HD. Meyers S, et al. Among authors: present dh. Scand J Gastroenterol Suppl. 1988;148:29-37. doi: 10.3109/00365528809101544. Scand J Gastroenterol Suppl. 1988. PMID: 2906474 Clinical Trial.
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. Targan SR, et al. Among authors: present dh. N Engl J Med. 1997 Oct 9;337(15):1029-35. doi: 10.1056/NEJM199710093371502. N Engl J Med. 1997. PMID: 9321530 Clinical Trial.
Methotrexate for Crohn's disease.
Korelitz BI, Present DH. Korelitz BI, et al. Among authors: present dh. N Engl J Med. 1995 Aug 31;333(9):600-1. doi: 10.1056/NEJM199508313330917. N Engl J Med. 1995. PMID: 7623920 No abstract available.
115 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page